Other factors, which were not available in our study, predict breast cancer risk and their inclusion may further improve the discrimination and clinical utility of our CBC risk model: these factors include CHEK2 c.1100del mutation carriers, polygenic risk scores based on common genetic variants, breast density, and reproductive and lifestyle factors such as BMI and age at menarche [75]. This evidence concerns the gene CHEK2 and breast cancer.